Location History:
- Rome, IT (2010)
- Milan, IT (2008 - 2011)
- Pomezia, IT (2012)
Company Filing History:
Years Active: 2008-2012
Title: Marco Chinol: Innovator in Radiopharmaceuticals
Introduction
Marco Chinol is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of radiopharmaceuticals, holding a total of 5 patents. His work focuses on enhancing the safety and efficacy of radiopharmaceuticals used in medical diagnostics and therapy.
Latest Patents
One of his latest patents is a "Container for vial of radiopharmaceutical and set for its infusion in a patient or for its transfer elsewhere." This innovative container is made of polymethyl methacrylate and features a receptacle with a cavity designed to hold the vial of radiopharmaceutical. The container is equipped with a lid that has a central through-hole, ensuring secure closure. Additionally, the set includes a bottle of saline solution and two infusion catheters, which enhance radioprotection during the infusion process. Another notable patent is for "Aminoderivative of biotin and their conjugates with macrocyclic chelating agents." This patent describes compounds that can be used for preparing conjugates with radionuclides, aimed at improving diagnostics and therapy for pathological conditions such as tumors.
Career Highlights
Marco Chinol has worked with reputable organizations, including Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. and Università Degli Studi Di Genova. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of radiopharmaceuticals.
Collaborations
Throughout his career, Marco has collaborated with notable professionals such as Giovanni Paganelli and Mauro Ginanneschi. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Marco Chinol is a distinguished inventor whose work in radiopharmaceuticals has the potential to significantly impact medical diagnostics and treatment. His innovative patents and collaborations highlight his commitment to advancing healthcare technology.